Tenaya Therapeutics ^Company

Tenaya Therapeutics is a biopharmaceutical company dedicated to discovering and developing therapies for heart failure. Tenaya was founded by world-class scientists from the Gladstone Institutes'​ Cardiovascular Division and UT Southwestern and is backed by The Column Group. Tenaya is building a research-driven organization that targets the fundamental cellular pathologies present in diseased cardiac muscle by leveraging cutting-edge science in cardiac regeneration, induced pluripotent stem cells, and CRISPR technologies.